Factors Associated with Adherence to Adjuvant Endocrine Therapy Among Privately Insured and Newly Diagnosed Breast Cancer Patients: A Quantile Regression Analysis

BACKGROUND: Adherence to adjuvant endocrine therapy (AET) for estrogen receptor-positive breast cancer remains suboptimal, which suggests that women are not getting the full benefit of the treatment to reduce breast cancer recurrence and mortality. The majority of studies on adherence to AET focus o...

Descripción completa

Detalles Bibliográficos
Autores principales: Farias, Albert J., Hansen, Ryan N., Zeliadt, Steven B., Ornelas, India J., Li, Christopher I., Thompson, Beti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4978119/
https://www.ncbi.nlm.nih.gov/pubmed/27459660
http://dx.doi.org/10.18553/jmcp.2016.22.8.969

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4978119/
https://www.ncbi.nlm.nih.gov/pubmed/27459660
http://dx.doi.org/10.18553/jmcp.2016.22.8.969

Ejemplares similares